Risk assessment of antibody-mediated damage based on the detection of HLA and non-HLA antibodies toward extracellular antigens before kidney transplantation
These findings suggest that non-HLA antibody assessment offers valuable complementary information, regardless of HLA sensitization, though appropriate cut-offs should be explored.
Authors
- Betty Chamoun (ORCID: https://orcid.org/0000-0002-4267-2273)
- Anna Buxeda (ORCID: https://orcid.org/0000-0001-7305-3259)
- Eulàlia Solà-Porta
- Marta Crespo (ORCID: https://orcid.org/0000-0001-6992-6379)
- Carla Burballa (ORCID: https://orcid.org/0000-0002-0091-1459)
- Sara Sanz-Ureña (ORCID: https://orcid.org/0000-0002-2230-3737)
- María José Pérez‐Sáez (ORCID: https://orcid.org/0000-0002-8601-2699)
- Dolores Redondo‐Pachón (ORCID: https://orcid.org/0000-0002-0458-0052)
- Elisenda Alari‐Pahissa (ORCID: https://orcid.org/0000-0001-7424-5383)
- Julio Pascual (ORCID: https://orcid.org/0000-0002-4735-7838)
- Judith Federico-Vega (ORCID: https://orcid.org/0000-0003-3943-1396)
- José Luís
- Javier Gimeno
- Jorge Eguía-Núñez
- Luís Campuzano
Institutions
- Generalitat de Catalunya (ES)
- Hospital Universitario 12 De Octubre (ES)
- Hospital Clínic de Barcelona (ES)
- Hospital Del Mar (ES)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-08-12
- DOI
- https://doi.org/10.3389/fimmu.2025.1614408
- Primary Topic
- Renal Transplantation Outcomes and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00